 14. Subject has active or prior documented autoimmune or inflammatory disorders including inflammatory bowel disease eg, colitis, Crohns disease, diverticulitis, celiac disease, irritable bowel disease, or other serious gastrointestinal chronic conditions associated with diarrhea; systemic lupus erythematosus; Wegener syndrome; myasthenia gravis; Graves disease; rheumatoid arthritis, hypophysitis, uveitis, etc within the past 3 years prior to the start of treatment. The following are exceptions to this criterion: 